日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies

从已批准药物库的高通量筛选中鉴定哈尔明和β-咔啉类似物;分析其作为DYRK1A和单胺氧化酶A差异性抑制剂的特性,并用于体外和体内抗癌研究。

Michael Tarpley ,Helen O Oladapo ,Dillon Strepay ,Thomas B Caligan ,Lhoucine Chdid ,Hassan Shehata ,Jose R Roques ,Rhashad Thomas ,Christopher P Laudeman ,Rob U Onyenwoke ,David B Darr ,Kevin P Williams

The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor

MMTV-Wnt1小鼠模型可产生两种表型不同的乳腺肿瘤亚型,这两种亚型对EGFR抑制剂的治疗反应各不相同。

Adam D Pfefferle ,David B Darr ,Benjamin C Calhoun ,Kevin R Mott ,Jeffrey M Rosen ,Charles M Perou

New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging

活体成像揭示黑色素瘤对 MEK 抑制剂产生耐药性的新机制

Hailey E Brighton #, Steven P Angus #, Tao Bo, Jose Roques, Alicia C Tagliatela, David B Darr, Kubra Karagoz, Noah Sciaky, Michael L Gatza, Norman E Sharpless, Gary L Johnson, James E Bear

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer

纳米颗粒结合的 STING 激活剂可增强 PD-L1 不敏感三阴性乳腺癌模型中的抗肿瘤免疫力

Ning Cheng, Rebekah Watkins-Schulz, Robert D Junkins, Clément N David, Brandon M Johnson, Stephanie A Montgomery, Kevin J Peine, David B Darr, Hong Yuan, Karen P McKinnon, Qi Liu, Lei Miao, Leaf Huang, Eric M Bachelder, Kristy M Ainslie, Jenny P-Y Ting2

Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer

载多西他赛的 PLGA 纳米粒子可提高紫杉醇耐药性三阴性乳腺癌的疗效

Charles J Bowerman, James D Byrne, Kevin S Chu, Allison N Schorzman, Amanda W Keeler, Candice A Sherwood, Jillian L Perry, James C Luft, David B Darr, Allison M Deal, Mary E Napier, William C Zamboni, Norman E Sharpless, Charles M Perou, Joseph M DeSimone

Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells

GLI1 的药理靶向抑制炎性乳腺癌细胞的增殖、肿瘤栓塞形成和体内肿瘤生长

Helen O Oladapo, Michael Tarpley, Scott J Sauer, Kezia A Addo, Shalonda M Ingram, Dillon Strepay, Ben K Ehe, Lhoucine Chdid, Michael Trinkler, Jose R Roques, David B Darr, Jodie M Fleming, Gayathri R Devi, Kevin P Williams

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity

高容量紫杉醇聚合物胶束:高剂量药物治疗对安全性和体内抗癌活性的影响

Zhijian He, Xiaomeng Wan, Anita Schulz, Herdis Bludau, Marina A Dobrovolskaia, Stephan T Stern, Stephanie A Montgomery, Hong Yuan, Zibo Li, Daria Alakhova, Marina Sokolsky, David B Darr, Charles M Perou, Rainer Jordan, Robert Luxenhofer, Alexander V Kabanov

Weight loss reduces basal-like breast cancer through kinome reprogramming

减肥可通过激酶组重编程减少基底样乳腺癌

Yuanyuan Qin, Sneha Sundaram, Luma Essaid, Xin Chen, Samantha M Miller, Feng Yan, David B Darr, Joseph A Galanko, Stephanie A Montgomery, Michael B Major, Gary L Johnson, Melissa A Troester, Liza Makowski

cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer

cMET 抑制剂克唑替尼可抑制基底样乳腺癌 C3(1)-Tag 模型中的血管生成并减轻肿瘤负担

Alyssa J Cozzo #, Sneha Sundaram #, Ottavia Zattra, Yuanyuan Qin, Alex J Freemerman, Luma Essaid, David B Darr, Stephanie A Montgomery, Kirk K McNaughton, J Ashley Ezzell, Joseph A Galanko, Melissa A Troester, Liza Makowski

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

共存的 ARID1A-PIK3CA 突变通过促肿瘤发生炎症细胞因子信号传导促进卵巢透明细胞肿瘤发生

Ronald L Chandler, Jeffrey S Damrauer, Jesse R Raab, Jonathan C Schisler, Matthew D Wilkerson, John P Didion, Joshua Starmer, Daniel Serber, Della Yee, Jessie Xiong, David B Darr, Fernando Pardo-Manuel de Villena, William Y Kim, Terry Magnuson